Mengyao Zhang

Mengyao Zhang

Auto-generated profile, based on publicly available information

Mengyao Zhang

Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
PHPeng He
Peng He
MZMi Zhang
Mi Zhang
MZMeng Zhao
Meng Zhao
MZMengyao Zhang
Mengyao Zhang
BMBenxu Ma
Benxu Ma
WZWenwen Zhao
Wenwen Zhao
We isolated and purified a novel polysaccharide from the root of Chuanminshen violaceum, namely, Chuanminshen violaceumis polysaccharide (CVP) and confirmed its structure and molecular weight. Furthermore, in vivo experiment, CVP’s protective effect against myocardial ischemia-reperfusion (I/R) injury in mice was evidenced by significantly reducing I/R-induced myocardial infarction (MI) size, decreasing the secretion of heart damage biomarkers, and improving cardiac function. Then, the myocardial anoxia/reoxygenation (A/R) injury model was established to mimic reperfusion injury. Noticeably, ferroptosis was the major death manner for A/R-damaged H9c2 cells. Meanwhile, CVP significantly inhibited ferroptosis by decreasing intracellular Fe2+ level, enhancing GPX4 expression, and suppressing lipid peroxidation to confront A/R injury. In conclusion, CVP, with a clear structure, ameliorated I/R injury by inhibiting ferroptosis.

11 September 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HFHui Feng
Hui Feng
YLYi Liu
Yi Liu
MZMengyao Zhang
Mengyao Zhang
RLRuimin Liu
Ruimin Liu
JWJincheng Wang
Jincheng Wang
FNFan Niu
Fan Niu